Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ISRCTN16869276) titled 'Deferred Registration: Quotient Sciences Code: QSC303955' on June 24.
Study Type: Interventional
Study Design:
Allocation: Non-randomized controlled trial
Masking: Open (masking not used)
Control: Active
Assignment: This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date.
Purpose: Phase I trial in healthy volunteers
Primary Sponsor: Skyhawk Therapeutics, Inc.
Condition:
Healthy volunteers
Other
Intervention:
This is a phase I trial in healthy volunteers only and qualifies for an automa...